$USB

Goldman Sachs Adjusts Price Target on U.S. Bancorp to $64 From $71, Keeps Neutral Rating

Goldman Sachs reduced its price target for U.S. Bancorp (USB) from $71 to $64, maintaining a neutral rating. The bank's shares were trading at $57.51, up 0.26%, in pre-market. The adjustment reflects changes in valuation and earnings per share revisions.

Original reporting
Published Oct 5, 2026, 11:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 11:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$USB
Bearish
high confidence
Mentioned
$USB
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$USBBearishMed
01

Why it matters

The downgrade signals reduced expectations for future profitability, which may prompt short sellers.

02

Market read

Analyst target cuts can move the stock and influence sector sentiment.

03

What to watch

Recent loan growth and deposit inflows that may offset the target reduction.

Relevance 5/10Novelty 5/10Timing: pre-market today

Background

Goldman Sachs adjusted its valuation model for U.S. Bancorp, lowering the price target by $7.

Company-level read

Ticker impact

$USBBearishHigh confidence
Context

Goldman Sachs cut its price target for U.S. Bancorp to $64 from $71, indicating a lower valuation outlook.

Expected impact

likely downward pressure as investors price in the lower target

Evidence & confidence

Analyst target cuts are a direct catalyst that often precede short-term price declines.

Market effects

May weigh on regional banking sector sentiment.

Potential modest dip in U.S. financial stocks.

Limited to U.S. banking equities.

Counterpoint

If the cut reflects temporary market overreaction, the stock could rebound on earnings beat.

Key entities

  • Goldman Sachs

    Equity research firm issuing the target change.

  • U.S. Bancorp

    Subject of the price target adjustment.

Related articles

$USBMed

US Bancorp (USB) Gets a Buy from Oppenheimer

Oppenheimer maintained a Buy rating on US Bancorp (USB) with a $72.00 price target. Truist Financial also issued a Buy, while J.P. Morgan kept a Hold. USB reported Q2 revenue of $10.92B and net profit of $2.18B, up from last year. Insider sentiment is negative, with recent sales by executives.

$USBMed

USB Maintains Rating by Evercore ISI Group -- Price Target Lower

Evercore ISI Group maintained an 'Outperform' rating on U.S. Bancorp (USB) but lowered its price target from $72.00 to $65.00, citing market conditions. USB's GF Value™ is $51.30, suggesting a 9.3% overvaluation. The company's GF Score™ is 84, indicating strong performance but with lower financial strength. Insider activity shows significant selling.

$USBMed

US Fed plans to raise bank oversight thresholds, sources say

The US Federal Reserve plans to raise asset thresholds for stricter oversight of big banks, according to sources. Current thresholds are $100B, $250B, and $700B. The Fed may reindex these, potentially benefiting banks like U.S. Bancorp, Capital One, and PNC Financial. Changes could spur consolidation among mid-size lenders and increase competition, but critics argue it may reduce consumer benefits and increase systemic risks.

$JPMHigh

Banks Lift Prime Rate to 7% as Fed Launches First Tightening Move Since 2023

Major U.S. banks, including JPMorgan, Bank of America, and Citigroup, raised their prime lending rates to 7% following the Federal Reserve's quarter-point increase in the federal funds rate to 3.75%-4%. The Fed cited persistent inflation. Bank stocks fell, reflecting mixed investor sentiment. The Fed projects further rate hikes, with implications for borrowers and the broader economy.